Analysis of amino acids in human blood using UHPLC-MS/MS: Potential interferences of storage time and vacutainer tube in pre-analytical procedure

Clinical Biochemistry

Volumn 49, Issue 18, 2016, Pages 1372-1378

  Xia, Tianyi ^a   Gao, Shouhong ^a   Shu, Chang ^a   Wen, Yan ^a   Yun, Yunlei ^a   Tao, Xia ^a   Chen, Wansheng ^a   Zhang, Feng ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Amino acid; Pre analytical phase; Storage time; Vacutainer tube

Indexed keywords

AMINO ACID; CITRIC ACID; EDETIC ACID; HEPARIN;

AMINO ACID ANALYSIS; ANALYSIS OF VARIANCE; ANALYTICAL ERROR; ARTICLE; BLAND ALTMAN MODEL; BLOOD COLLECTION TUBE; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; MATHEMATICAL MODEL; MAUCHLY SPHERICITY TEST; NORMAL HUMAN; PASSING BABLOK REGRESSION ANALYSIS; PLASMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REGRESSION ANALYSIS; SERUM; STATISTICAL ANALYSIS; STORAGE; STUDENT T TEST; TANDEM MASS SPECTROMETRY; TIME; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; BLOOD; BLOOD SAMPLING; DEVICES; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PROCEDURES; SPECIMEN HANDLING;

AMINO ACIDS; BLOOD SPECIMEN COLLECTION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; SPECIMEN HANDLING; TANDEM MASS SPECTROMETRY;

EID: 84992111590     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2016.09.018     Document Type: Article

References (38)

1. [1] Wu, G.Y., Functional amino acids in nutrition and health. Amino Acids 45 (2013), 407–411, 10.1007/s00726-013-1500-6.
2. [2] Bertrand, J., Goichon, A., Déchelotte, P., Coëffier, M., Regulation of intestinal protein metabolism by amino acids. Amino Acids 45 (2012), 443–450, 10.1007/s00726-012-1325-8.
3. [3] Fernstrom, J.D., Fernstrom, M.H., Tyrosine phenylalanine, and catecholamine synthesis and function in the brain. J. Nutr. 137 (2007), 1539S–1547S, 10.1371/journal.pone.0132223.
4. [4] Christians, U., Schmitz, V., Schöning, W., Bendrick-Peart, J., Klawitter, J., Haschke, M., et al. Toxicodynamic therapeutic drug monitoring of immunosuppressants: promises, reality, and challenges. Ther. Drug Monit. 30 (2008), 151–158, 10.1097/FTD.0b013e31816b9063.
5. [5] Ihata, Y., et al. Amino acid profile index for early detection of endometrial cancer: verification as a novel diagnostic marker. Int. J. Clin. Oncol. 19 (2014), 364–372, 10.1007/s10147-013-0565-2.
6. [6] Sasabe, J., Suzuki, M., Miyoshi, Y., Tojo, Y., Okamura, C., Ito, S., et al. Ischemic acute kidney injury perturbs homeostasis of serine enantiomers in the body fluid in mice: early detection of renal dysfunction using the ratio of serine enantiomers. PLoS One, 9, 2014, e86504, 10.1371/journal.pone.0086504.
7. [7] Ashakiran, S., Sumati, M.E., Murthy, N.K., A study of pre-analytical variables in clinical biochemistry laboratory. Clin. Biochem. 44 (2011), 944–945, 10.1016/j.clinbiochem.2011.05.003.
8. [8] Lippi, G., Blanckaert, N., Bonini, P., Green, S., Kitchen, S., Palicka, V., et al. Causes, consequences, detection, and prevention of identification errors in laboratory diagnostics. Clin. Chem. Lab. Med. 47 (2009), 143–153, 10.1515/CCLM.2009.045.
9. [9] Plebani, M., Sciacovelli, L., Aita, A., Padoan, A., Chiozza, M.L., Quality indicators to detect pre-analytical errors in laboratory testing. Clin. Chim. Acta 432 (2014), 44–48, 10.1016/j.cca.2013.07.033.
10. [10] Banfi, G., Dolci, A., Preanalytical phase of sport biochemistry and haematology. J. Sports Med. Phys. Fitness 43:2 (2003), 223–230.
11. [11] Tatsumi, N., Miwa, S., Lewis, S.M., Specimen collection, storage, and transmission to the laboratory for hematological tests. Int. J. Hematol. 75 (2002), 261–268, 10.1007/BF02982039.
12. [12] Wagar, E.A., Tamashiro, L., Yasin, B., Hilborne, L., Bruckner, D.A., Patient safety in the clinical laboratory: a longitudinal analysis of specimen identification errors. Arch. Pathol. Lab. Med. 130 (2006), 1662–1668, 10.1043/1543–2165(2006)130[645:DCSIAP]2.0.CO;2.
13. [13] Dzik, W.H., Murphy, M.F., Andreu, G., Heddle, N., Hogman, C., Kekomaki, R., et al. An international study of the performance of sample collection from patients. Vox Sang. 85 (2003), 40–47, 10.1046/j.1423-0410.2003.00313.x.
14. [14] Calmarza, P., Cordero, J., Lipemia interferences in routine clinical biochemical tests. Biochem. Med. (Zagreb) 21 (2011), 160–166, 10.11613/BM.2011.025.
15. [15] Meisner, M., Tschaikowsky, K., Schnabel, S., Schmidt, J., Katalinic, A., Schüttler, J., Procalcitonin-influence of temperature, storage, anticoagulation and arterial or venous asservation of blood samples on procalcitonin concentrations. Eur. J. Clin. Chem. Clin. Biochem. 35 (1997), 597–601, 10.1515/cclm.1997.35.8.597.
16. [16] Bowen, R.A., Chan, Y., Cohen, J., Rehak, N.N., Hortin, G.L., Csako, G., et al. Effect of blood collection tubes on total triiodothyronine and other laboratory assays. Clin. Chem. 51 (2005), 424–433, 10.1373/clinchem.2004.043349.
17. [17] Bowen, R.A., Vu, C., Remaley, A.T., Hortin, G.L., Csako, G., Differential effect of blood collection tubes on total free fatty acids. (FFA) and total triiodothyronine. (TT3) concentration: a model for studying interference from tube constituents. Clin. Chim. Acta 378 (2007), 181–193, 10.1016/j.cca.2006.11.020.
18. [18] Pereira, M., Azevedo, A., Severo, M., Barros, H., Long-term stability of endogenous B-type natriuretic peptide during storage at − 20 °C for later measurement with Biosite triage assay. Clin. Biochem. 40 (2007), 1104–1107.
19. [19] Chan, H., Lunt, H., Thompson, H., Heenan, H.F., Frampton, C.M., Florkowski, C.M., Plasma glucose measurement in diabetes: impact and implications of variations in sample collection procedures with a focus on the first hour after sample collection. Clin. Chem. Lab. Med. 52 (2014), 1061–1068, 10.1515/cclm-2013-1059.
20. [20] Davids, M., Peters, J.H.C., de Jong, S., Teerlink, T., Measurement of nitric oxide-related amino acids in serum and plasma: effects of blood clotting and type of anticoagulant. Clin. Chim. Acta 421 (2013), 164–167, 10.1016/j.cca.2013.03.009.
21. [21] Chuang, C.K., Lin, S.P., Lin, Y.T., Huang, F.Y., Effects of anticoagulants in amino acid analysis: comparisons of heparin, EDTA, and sodium citrate in vacutainer tubes for plasma preparation. Clin. Chem. 4 (1998), 1052–1056.
22. [22] Chen, Y.H., Shi, W., Liang, X.L., Liang, Y.Z., Fu, X., Effect of blood sample type on the measurement of advanced oxidation protein products as a biomarker of inflammation and oxidative stress in hemodialysis patients. Biomarkers 16 (2011), 129–135, 10.3109/1354750X.2010.535172.
23. [23] Kahn, N., Riedlinger, J., Roeßler, M., Rabe, C., Lindner, M., Koch, I., et al. Blood-sampling collection prior to surgery may have a significant influence upon biomarker concentrations measured. Clin. Proteomics, 12, 2015, 19, 10.1186/s12014-015-9093-6.
24. [24] Zhao, Z., Xiao, Y., Elson, P., Tan, H., Plummer, S.J., Berk, M., et al. Plasma lysophosphatidylcholine levels: potential biomarkers for colorectal cancer. J. Clin. Oncol. 25 (2007), 2696–2701, 10.1200/JCO.2006.08.5571.
25. [25] Petricoin, E.F., Belluco, C., Araujo, R.P., Liotta, L.A., The blood peptidome: a higher dimension of information content for cancer biomarker discovery. Nat. Rev. Cancer 6 (2006), 961–967, 10.1038/nrc2011.
26. [26] Ciordia, S., de Los, R.V., Albar, J.P., Contributions of advanced proteomics technologies to cancer diagnosis. Clin. Transl. Oncol. 8 (2006), 566–580, 10.1007/s12094-006-0062-4.
27. [27] Barri, T., Dragsted, L.O., UPLC-ESI-QTOF/MS and multivariate data analysis for blood plasma and serum metabolomics: effect of experimental artefacts and anticoagulant. Anal. Chim. Acta 768 (2013), 118–128, 10.1016/j.aca.2013.01.015.
28. [28] Teerlink, T., HPLC analysis of ADMA and other methylated L-arginine analogs in biological fluids. J. Chromatogr. B 851 (2007), 21–29, 10.1016/j.jchromb.2006.07.024.
29. [29] Yu, Z., Kastenmüller, G., He, Y., Belcredi, P., Möller, G., Prehn, C., et al. Differences between human plasma and serum metabolite profiles. PLoS One, 6, 2011, e21230, 10.1371/journal.pone.0021230.
30. [30] Passing, H., Bablok, W., A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I. J. Clin. Chem. Clin. Biochem. 21 (1983), 709–720, 10.1515/cclm.1983.21.11.709.
31. [31] Bland, J.M., Altman, D.G., Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 47 (2010), 931–936, 10.1016/j.ijnurstu.2009.10.001.
32. [32] Wiwanitkit, V., Types and frequency of preanalytical mistakes in the first Thai ISO 9002: 1994 certified clinical laboratory, a 6-month monitoring. BMC Clin. Pathol., 1, 2001, 5, 10.1186/1472-6890-1-5.
33. [33] Kouria, T., Siloahob, M., Pohjavaarac, S., Koskinend, P., Malminiemie, O., et al. Pre-analytical factors and measurement uncertainty. Scand. J. Clin. Lab. Invest. 65 (2005), 463–476, 10.1080/00365510500208332.
34. [34] Goswami, B., Singh, B., Chawla, R., Mallika, V., Evaluation of errors in a clinical laboratory: a one-year experience. Clin. Chem. Lab. Med. 48 (2010), 63–66, 10.1515/CCLM.2010.006.
35. [35] Szecsi, P.B., Ødum, L., Error tracking in a clinical biochemistry laboratory. Clin. Chem. Lab. Med. 47 (2009), 1253–1257, 10.1515/CCLM.2009.272.
36. [36] Lima-Oliveira, G., Lippi, G., Salvagno, G.L., Montagnana, M., Poli, G., Solero, G.P., et al. Brand of dipotassium EDTA vacuum tube as a new source of pre-analytical variability in routine haematology testing. Br. J. Biomed. Sci. 70 (2013), 6–9, 10.1080/09674845.2013.11669922.
37. [37] Van Cott, E.M., Lewandrowski, K.B., Patel, S., Grzybek, D.Y., Patel, H.S., Fletcher, S.R., et al. Comparison of glass K3EDTA versus plastic K2EDTA blood-drawing tubes for complete blood counts, reticulocyte counts, and white blood cell differentials. Lab. Hematol. 9 (2003), 10–14.
38. [38] Bowen, R.A., Chan, Y., Ruddel, M.E., Hortin, G.L., Csako, G., Demosky, S.J. Jr., et al. Immunoassay interference by a commonly used blood collection tube additive, the organosilicone surfactant silwet L-720. Clin. Chem. 51 (2005), 1874–1882, 10.1373/clinchem.2005.055400.